Home › NDC Lookup › RxCUI directory › RxCUI 1052670

Acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule — RxCUI 1052670

RxNorm drug concept · Semantic clinical drug
RxCUI 1052670 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1052670
Official nameAcetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule; acetaminophen 325 MG / phenylephrine HCl 5 MG Oral Capsule
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Acetaminophen 325 MG / phenylephrine hydrochlori... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule RxCUI 1052670

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Phenylephrine 8163
    • Acetaminophen / phenylephrine 214186
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / phenylephrine Oral Capsule 450691
    • Acetaminophen / phenylephrine hydrochloride Oral Capsule 2645815
    • Acetaminophen / phenylephrine Oral Product 1151913
    • Acetaminophen / phenylephrine Pill 1151914
    • Acetaminophen / phenylephrine hydrochloride Oral Product 2663092
    • Acetaminophen / phenylephrine hydrochloride Pill 2662558
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 325 MG 315263
    • Phenylephrine hydrochloride 5 MG 1020198
  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack 2634822

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 325 MG SCDC · 315263
  • Phenylephrine hydrochloride 5 MG SCDC · 1020198
  • Acetaminophen / phenylephrine Oral Capsule SCDF · 450691
  • Acetaminophen / phenylephrine hydrochloride Oral Capsule SCDFP · 2645815
  • Acetaminophen / phenylephrine Oral Product SCDG · 1151913
  • Acetaminophen / phenylephrine Pill SCDG · 1151914
  • Acetaminophen / phenylephrine hydrochloride Oral Product SCDGP · 2663092
  • Acetaminophen / phenylephrine hydrochloride Pill SCDGP · 2662558
  • {1 (acetaminophen 325 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack GPCK · 2634822

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1052670 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
37000-0950-24 2 BLISTER PACK in 1 CARTON (37000-950-24) / 12 CAPSULE, LIQ... Vicks Sinex Severe All in One Sinus The Procter & Gamble Manufacturing Company 2018-07-10
53345-0012-01 1 BAG in 1 BOX (53345-012-01) / 4000 CAPSULE, LIQUID FILLED... DayTime Sinus Relief Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. 2013-06-15
53345-0030-01 1 BAG in 1 BOX (53345-030-01) / 4000 CAPSULE, LIQUID FILLED... DayTime Sinus Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. 2015-02-26
82706-0025-01 3 BLISTER PACK in 1 CARTON (82706-025-01) / 8 CAPSULE, LIQU... Sinus Head Congestion VIVUNT PHARMA LLC 2025-03-18
Observed labelers: Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. (1) · Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. (1) · The Procter & Gamble Manufacturing Company (1) · VIVUNT PHARMA LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.